Chief Executive Officer
Viroclinics Biosciences BV
Jul 2020 - Aug 2022 (2 years 2 months)
Viroclinics operates at a global level, being the preferred virology testing laboratory for several of the top-10 Biopharmaceutical companies. As a virology contract research organization, Viroclinics serves the biopharmaceutical community with preclinical, clinical diagnostic, research & development, and clinical trial logistics services. The extensive experience in clinical and preclinical virology research allows the company to support the development of vaccines, antibodies and antiviral drugs targeting viral infectious diseases. Viroclinics was acquired by Cerba Healthcare in February 2022.